Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Endogenous production of leukotriene D4 mediates autocrine survival and proliferation via CysLT1 receptor signalling in intestinal epithelial cells

Oncogene volume 25, pages 6660–6665 (2006)Cite this article

Abstract

The cysteinyl leukotriene1 (CysLT1) receptor (CysLT1R) enhances survival and proliferation of intestinal cells via distinct pathways. Here, we have demonstrated that there is significant endogenous production of CysLTs from both non-tumour- and tumour-derived intestinal epithelial cells. Treatment of two non-tumour cell lines, Int 407 and IEC-6, with CysLT1R antagonists led to shrinkage and detachment of cells, confirmed as apoptotic cell death, and a dose-dependent reduction in proliferation. However, in the tumour intestinal cell lines Caco-2, SW480, HCT-116 and HT-29, treatment with CysLT1R antagonists significantly reduced proliferation, but had no effect on apoptosis. A unique characteristic of intestinal cancer cells is the presence of nuclear CysLT1Rs, which are inaccessible to receptor antagonists. In these cells, inhibition of the endogenous production of CysLTs indirectly, by 5-lipoxygenase inhibition, impaired CysLT1R signalling throughout the cell, and resulted in apoptosis of the tumour cells. These data reveal the existence of constitutive CysLT1R signalling that mediates both survival and proliferation in intestinal cells. Importantly, we propose that tumour-derived intestinal cells are resistant to CysLT1R antagonist-induced apoptosis, a phenomena that could be explained by nuclear CysLT1R signalling.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Brink C, Dahlen SE, Drazen J, Evans JF, Hay DW, Nicosia S et al. (2003). Pharmacol Rev 55: 195–227.

  • Claesson HE, Dahlen SE . (1999). J Intern Med 245: 205–227.

  • Funk CD . (2001). Science 294: 1871–1875.

  • Ghosh J, Myers CE . (1998). Proc Natl Acad Sci USA 95: 13182–13187.

  • Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS et al. (2000). J Biol Chem 275: 30531–30536.

  • Hennig R, Ding XZ, Tong WG, Witt RC, Jovanovic BD, Adrian TE . (2004). Cancer Lett 210: 41–46.

  • Lee E, Robertson T, Smith J, Kilfeather S . (2000). Am J Respir Crit Care Med 161: 1881–1886.

  • Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM et al. (1999). Nature 399: 789–793.

  • Maekawa A, Austen KF, Kanaoka Y . (2002). J Biol Chem 277: 20820–20824.

  • Mann JR, DuBois RN . (2004). Cancer J 10: 145–152.

  • Murakami M, Nakatani Y, Atsumi G, Inoue K, Kudo I . (1997). Crit Rev Immunol 17: 225–283.

  • Nielsen CK, Campbell JI, Öhd JF, Mörgelin M, Riesbeck K, Landberg G et al. (2005). Cancer Res 65: 732–742.

  • Öhd JF, Nielsen CK, Campbell J, Landberg G, Löfberg H, Sjölander A . (2003). Gastroenterology 124: 57–70.

  • Öhd JF, Wikström K, Sjölander A . (2000). Gastroenterology 119: 1007–1018.

  • Pace J, Hayman MJ, Galan JE . (1993). Cell 72: 505–514.

  • Pachernik J, Hampl A, Soucek K, Kovarikova M, Andrysik Z, Hofmanova J et al. (2002). Arch Dermatol Res 293: 626–633.

  • Paruchuri S, Hallberg B, Juhas M, Larsson C, Sjölander A . (2002). J Cell Sci 115: 1883–1893.

  • Paruchuri S, Sjölander A . (2003). J Biol Chem 278: 45577–45585.

  • Shi ZZ, Han B, Habib GM, Matzuk MM, Lieberman MW . (2001). Mol Cell Biol 21: 5389–5395.

  • Wikström K, Juhas M, Sjölander A . (2003). Biochem J 371: 115–124.

  • Wu X, Biswal SS, Kehrer JP . (2003). Cell Biol Toxicol 19: 135–143.

Download references

Acknowledgements

This work was supported by grants awarded to the authors as follows: to AS from the Swedish Cancer Foundation, the Swedish Medical Research Council, the Foundations at Malmö University Hospital, the Ruth and Richard Julin Foundation, Zoega's Foundation, Gunnar Nilsson's Foundation and the Österlund Foundation; to SP and MM from the Royal Physiographic Society in Lund.

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine, Cell and Experimental Pathology, Lund University, Malmö University Hospital, Malmö, Sweden

    S Paruchuri, M Mezhybovska, M Juhas & A Sjölander

Authors
  1. S Paruchuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Mezhybovska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Juhas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Sjölander
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Sjölander.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paruchuri, S., Mezhybovska, M., Juhas, M. et al. Endogenous production of leukotriene D4 mediates autocrine survival and proliferation via CysLT1 receptor signalling in intestinal epithelial cells. Oncogene 25, 6660–6665 (2006). https://doi.org/10.1038/sj.onc.1209666

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209666

Keywords

This article is cited by

Search

Advanced search

Quick links